Poland· PL-100515431
Elocom
A mometasone product containing mometasoni furoas, registered in Poland by Allpharm Sp. z o.o. sp.k.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mometasone is registered in 15 of 19 countries.
Countries holding a registration under ATC D07AC13 (mometasone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Mometasone · ATC D07AC13
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Mometasoni furoas
- Manufacturer
- Allpharm Sp. z o.o. sp.k.
- Country
- Poland (PL)
- ATC code
- D07AC13
- ATC class
- Mometasone
- Defined daily dose
- 1 mg, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991567934
- gtin05909991567941
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mometasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMometasone furoateEncube Ethicals, Inc.
- CzechiaELOCOMN.V. Organon, Oss
- SwedenDemoson 1 mg/g SalvaViatris Limited
- FinlandDemosonViatris Limited
- NetherlandsMometasonfuroaat Glenmark 1 mg/g, zalfGlenmark Arzneimittel GmbH
- SwitzerlandElocom
- SpainELOCOM 1 mg/g POMADAOrganon Salud S.L.
- IcelandEloconN.V. Organon*
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Asmanex Twisthaler, Elocon
- Belgium · Asmanex Twisthaler, Elocom
- Bulgaria · Блоктимо, Елоком
- Cyprus · Elocon, Movesan
- Czechia · Asmanex, Elocom
- Germany · Allergo-Momelind, Asmanex Twisthaler
- Denmark · Aphiahsone, Asmanex Twisthaler
- Estonia · Breso, Elocon
- Spain · Asmanex Twisthaler, Elocom
- Finland · Asmanex Twisthaler, Demoson
- France · Asmanex Twisthaler, Mometasone Arrow
- United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
- Greece · Asmanex Twisthaler, Elocon
- Croatia · Elocom, Momanose
- Hungary · Azocutan, Elocom
- Ireland · Asmanex Twisthaler, Elocon
- Iceland · Elocon, Kalmente
- Italy · Arinit, Asmanex
- Lithuania · Breso, Elocon
- Luxembourg · Elocom, Monovo
- Latvia · Breso, Elocon
- Malta · Elocon, Nasonex
- Netherlands · Elocon, Elocon Vet
- Norway · Asmanex Twisthaler, Elocon
- Portugal · Asmanex Twisthaler, Desdek
- Romania · Elocom, Furoat De Mometazonă Cipla
- Sweden · Aphiahsone, Asmanex Twisthaler
- Slovenia · Asmanex Twisthaler, Elocom
- Slovakia · Asmanex, Elocom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e56ef529-e3e7-4aaf-b88f-b75efbdf5843 GET /v1/drugs/e56ef529-e3e7-4aaf-b88f-b75efbdf5843?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "1 mg/g",
"packaging": "05909991567934 ¦ Rp ¦ 161067\n1 tuba 15 g\n05909991567941 ¦ Rp ¦ 161068\n1 tuba 30 g",
"substance": "Mometasoni furoas 1 mg/g",
"common_name": "Mometasoni furoas",
"pl_product_id": "100515431",
"pozwolenie_nr": "100/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-03-17"
}See everything about mometasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.